lung%20cancer
LUNG CANCER
Lung cancer is having a malignant tumor in the lungs especially in the cells lining air passages.
Primary tumor-related signs and symptoms are cough, dyspnea, hemoptysis, and chest discomfort.
Signs and symptoms due to intrathoracic spread may involve the nerves (hoarseness, dyspnea, muscle wasting of upper limb, Horner's syndrome), chest wall and pleura (chest pain, dyspnea) and vascular structures (facial swelling, dilated neck veins, cardiac tamponade) & viscera (dsyphagia).
The signs and symptoms due to metastatic spread are bone pain with or without pleuritic pain, neurologic symptoms, limb weakness, unsteady gait, cervical lymphadenopathy, and skin nodules.
  1. Chu Q, Vincent M, Logan D, et al; Lung Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-based Care. Taxanes as first-line therapy for advanced non-small cell lung cancer: a systematic review and practice guideline. Lung Cancer. 2005 Dec;50(3):355-374. PMID: 16139391
  2. Alberts WM. Diagnosis and management of lung cancer executive summary: ACCP evidence-based clinical practice guidelines (2nd Edition). Chest. 2007 Sep;132(3 Suppl):1S-19S. Accessed 02 Jul 2010. PMID: 17873156
  3. D'Addario G, Felip E; ESMO Guidelines Working Group. Non-small-cell lung cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol. 2008 May;19(Suppl 2):ii39-ii40. doi: 10.1093/annonc/mdn081. Accessed 02 Jul 2010. PMID: 18456762
  4. Felip E, Sorensen M. Small-cell lung cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol. 2008;19:ii41-ii42. Accessed 02 Jul 2010
  5. Collins LG, Enck RE, Haines C, et al. Lung cancer: diagnosis and management. Am Fam Physician. 2007 Jan;75(1):56-63. Accessed 02 Jul 2010. PMID: 17225705
  6. Hanna N, Shepherd FA, Fossella FV, et al. Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy. J Clin Oncol. 2004 May;22(9):1589-1597. PMID: 15117980
  7. Jhun BW, Park HY, Jeon K, et al. Nodal stations and diagnostic performances of endobronchial ultrasound-guided transbronchial needle aspiration in patients with non-small cell lung cancer. J Korean Med Sci. 2012 Jan;27(1):46-51. doi: 10.3346/jkms.2012.27.1.46. Accessed 15 Oct 2012. PMID: 22219613
  8. Hotta K, Matsuo K, Ueoka H, et al. Role of adjuvant chemotherapy in patients with resected non-small-cell lung cancer: reappraisal with a meta-analysis of randomized controlled trials. J Clin Oncol. 2004 Oct;22(19):3860-3867. PMID: 15326194
  9. Johnson DH, Fehrenbacher L, Novotny WF, et al. Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer. J Clin Oncol. 2004 Jun;22(11):2184-2191. PMID: 15169807
  10. Lee BE, Kletsman E, Rutledge JR, Korst RJ. Utility of endobronchial ultrasound-guided mediastinal lymph node biopsy in patients with non-small cell lung cancer [Abstract]. J Thorac Cardiovasc Surg. 2012 Mar;143(3):585-590. doi: 10.1016/j.jtcvs.2011.11.022. [DateAccess]
  11. Laurie SA, Logan D, Markaman BR, et al; Lung Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-based Care. Practice guideline for the role of combination chemotherapy in the initial management of limited-stage small-cell lung cancer. Lung Cancer. 2004 Feb;43(2):223-240. PMID: 14739044
  12. Sheperd FA, rodrigues PJ, Ciuleanu T, eta al; National Cancer Institute of Canada Clinical Trials Group. Erlotinib in previously treated non-small-cell lung cancer. N Engl J Med. 2005 Jul;353(2):123-132. PMID: 16014882
  13. Pfister DG, Johnson DH, Azzoli CG, et al; American Society of Clinical Oncology. American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003. J Clin Oncol. 2004 Jan;22(2):330-353. PMID: 14691125
  14. Rinaldi M, Cauchi C, Gridelli C. First line chemotherapy in advanced or metastatic NSCLC. Ann Oncol. 2006 May;17(Suppl 5):v64-v67. PMID: 16807466
  15. Yasufuku K, Pierre A, Darling G, et al. A prospective controlled trial of endobronchial ultrasound-guided transbronchial needle aspiration compared with mediastinoscopy for mediastinal lymph node staging of lung cancer [Abstract]. J Thorac Cardiovasc Surg. 2011 Dec;142(6):1393-1400. doi: 10.1016/j.jtcvs.2011.08.037. Accessed 15 Oct 2012. PMID: 21963329
  16. Thatcher N, Chang A, Parikh P, et al. Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer). Lancet. 2005 Oct;366(9496):1527-1537. PMID: 16257339
  17. Blood Test Detects Lung CancerA blood test that detects a combination of proteins can distinguish between early lung cancer and noncancerous lung nodules, according to a study published in Science Translational Medicine. The two types of nodules are currently difficult to distinguish using imaging. The test showed a 90% negative predictive value in a study of 104 patient samples from three clinical sites. Further validation on 37 samples from a single site showed a 94% negative predictive valueCancer Network; 2013 Oct22 Oct 2013http://www.cancernetwork.com/lung-cancer/blood-test-detects-lung-cancer
  18. Glisson BS, Movsas B, Scott W. Small-cell lung cancer, mesothelioma, and thymoma. In: Camhausen KA, Hoskins WJ, Pazdur R, Wagman LD. Cancer Management: a multidisciplinary approach. 12th ed. Nowalk: CMP Healthcare Media LLC; 2009:117-126
  19. Kernstine KH, Khuri FR, Movsas B. Non small-cell lung cancer. In: Camhausen KA, Hoskins WJ, Pazdur R, Wagman LD. Cancer Management: a multidisciplinary approach. 12th ed. Nowalk: CMP Healthcare Media LLC; 2009:71-115
  20. MedWormhttp://www.medworm.com/rss/index.php/Cancer-%26-Oncology/6/http://www.medworm.com/rss/medicalfeeds/specialities/Cancer-Oncology.xml
  21. MedWormhttp://www.medworm.com/rss/index.php/Respiratory-Medicine/40/http://www.medworm.com/rss/medicalfeeds/specialities/Respiratory-Medicine.xml
  22. Eastern Cooperative Oncology Group. ECOG performance status. http://ecog.dfci.harvard.edu/general/perf_stat.html. Accessed 07 Jul 2010
  23. The Hong Kong Anti-cancer Society. Guidelines on cancer prevention, early detection & screening: Lung Cancer. http://www.hkacs.org.hk/uploadimages/download/00143/Guideline%20on%20lung%20cancer%20prevention,%20detection%20&%20screening%20%28full%20recommendation%29.pdf. Nov 2008. Accessed 02 Jul 2010
  24. Ministry of Health Singapore. Cancer Screening. MOH clinical practice guideline. MOH (Singapore). http://www.moh.gov.sg/content/dam/moh_web/HPP/Doctors/cpg_medical/current/2010/cpg_Cancer%20Screening%20Booklet%20FINAL%20v6.pdf. Feb 2010. Accessed 02 Jul 2010
  25. American Cancer Society. Lung cancer (small cell). http://www.cancer.org/cancer/lungcancer-smallcell/detailedguide/index. Jun 2010. Accessed 07 Feb 2010
  26. American Cancer Society. Lung cancer (non-small cell). http://www.cancer.org/cancer/lungcancer-non-smallcell/detailedguide/index. Dec 2009. Accessed 07 Feb 2010
  27. U.S. Preventive Services Task Force. Lung cancer screening. Recommendation statement. http://www.uspreventiveservicestaskforce.org/uspstf/uspslung.htm. 2004. Accessed 02 Jul 2010
  28. National Institute for Health and Care Excellence. Lung Cancer: the diagnosis and treatment of lung cancer. NICE clinical guideline 121. NICE. http://www.nice.org.uk/nicemedia/live/13465/54202/54202.pdf. Apr 2011. Accessed 15 Oct 2012
  29. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: non-small cell lung cancer. Version 3. NCCN. http://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf. 2012. Accessed 15 Oct 2012
  30. Scottish Intercollegiate Guidelines Network. Management of patients with lung cancer: a national clinical guideline. SIGN. http://www.sign.ac.uk/pdf/sign80.pdf. Feb 2005. Accessed 02 Jul 2010
  31. National Cancer Institute. Small cell lung cancer treatment. http://www.cancer.gov/cancertopics/pdq/treatment/small-cell-lung/Patient/page1. Jul 2009. Accessed 05 Jul 2009
  32. National Cancer Institute. Non-small cell lung cancer treatment. http://www.cancer.gov/cancertopics/pdq/treatment/non-small-cell-lung/Patient/page1. Jun 2010. Accessed 05 Jul 2010
  33. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: small cell lung cancer. Version 2. NCCN. http://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf. 2012. Accessed 15 Oct 2012
  34. National Collaborating Centre for Acute Care. The diagnosis and treatment of lung cancer. http://www.nice.org.uk/nicemedia/pdf/cg024niceguideline.pdf. 2005. Accessed 02 Jul 2010
  35. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: small cell lung cancer. Version 1. 2015. National Comprehensive Cancer Network. http://www.nccn.org/professionals/physician_gls/pdf/sclc.pdf. 2015. Accessed 10 Sep 2014.
  36. Scottish Intercollegiate Guidelines Network (SIGN). SIGN 137: Management of lung cancer. Scottish Intercollegiate Guidelines Network (SIGN). http://www.sign.ac.uk/pdf/SIGN137.pdf. Feb 2014. Accessed 10 Sep 2014.
  37. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: non-small cell lung cancer. Version 7.2015. NCCN website. http://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf. 2015.
  38. Eberhardt WE, De Ruysscher D, Weder W, et al; Panel Members. 2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer. Ann Oncol. 2015 Aug;26(8):1573-1588. http://www.esmo.org/Guidelines/Lung-and-Chest-Tumours/Consensus-Guidelines-Locally-advanced-stage-III-non-small-cell-lung-cancer-NSCLC. PMID: 25897013
  39. Kauczor HU, Bonomo L, Gaga M, et al; European Society of Radiology (ESR); European Respiratory Society (ERS). ESR/ERS white paper on lung cancer screening. Eur Respir J. 2015 Jul;46(1):28-39. http://erj.ersjournals.com/content/erj/46/1/28.full.pdf. PMID: 25929956
  40. Moyer VA; U.S. Preventive Services Task Force. Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2014 Mar;160(5):330-338. http://annals.org/data/Journals/AIM/929811/0000605-201403040-00008.pdf. PMID: 24378917
  41. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: adult cancer pain. Version 2.2016. NCCN website. https://www.nccn.org/professionals/physician_gls/pdf/pain.pdf. Mar 2016. Accessed 29 Jul 2016.
  42. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: lung cancer screening. Version 2.2016. NCCN website. https://www.nccn.org/professionals/physician_gls/pdf/lung_screening.pdf. 2016.
  43. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: non-small cell lung cancer. Version 4.2016. NCCN website. https://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf. 2016.
  44. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: palliative care. Version 1.2016. NCCN website. https://www.nccn.org/professionals/physician_gls/pdf/palliative.pdf. 2016.
  45. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: non-small cell lung cancer. Version 2.2017. NCCN website. https://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf. Oct 2016.
  46. Detterbeck FC, Boffa DJ, Kim AW, et al. The eighth edition lung cancer stage classification. Chest. 2017 Jan;151(1):193-203. doi: 10.1016/j.chest.2016.10.010. PMID: 27780786
  47. Früh M, De Ruysscher D, Popat S, Crinò L, Peters S, Felip E; ESMO Guidelines Working Group. Small-cell lung cancer (SCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013 Oct;24(Suppl 6):vi99-105. doi: 10.1093/annonc/mdt178. PMID: 23813929
  48. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: lung cancer screening. Version 8.2017. NCCN. https://www.nccn.org/. Jul 2017.
  49. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: non-small cell lung cancer. Version 1.2018. NCCN. https://www.nccn.org/. Jun 2017.
  50. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: small cell lung cancer. Version 3.2017. NCCN. https://www.nccn.org/. Feb 2017.
  51. Thomas KW, Gould MK. Overview of the initial evaluation, diagnosis, and staging of patients with suspected lung cancer. UptoDate. www.uptodate.com. Jul 2016.
  52. Hanna N, Johnson D, Temin S, et al. Systemic therapy for stage IV non-small-cell lung cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2017 Oct;35(30):3484-3515. doi: 10.1200/JCO.2017.74.6065. PMID: 28806116
  53. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: non-small cell lung cancer. Version 5.2018. NCCN. https://www.nccn.org/. Jun 2018.
  54. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: small cell lung cancer. Version 2.2018. NCCN. https://www.nccn.org/. Jan 2018.
  55. National Institute for Health and Clinical Excellence. Nintedanib for previously treated locally advanced, metastatic, or locally recurrent non-small-cell lung cancer. NICE. http://www.nice.org.uk/. Jul 2015.
  56. Travis WD, Brambilla E, Nicholson AG, et al; WHO Panel. The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification. J Thorac Oncol. 2015 Sep;10(9):1243-1260. doi: 10.1097/JTO.0000000000000630. PMID: 26291008
  57. MacMahon H, Naidich DP, Goo JM, et al. Guidelines for management of incidental pulmonary nodules detected on CT images: from the Fleischner Society 2017. Radiology. 2017 Jul;284(1):228-243. doi: 10.1148/radiol.2017161659. PMID: 28240562
  58. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: small cell lung cancer. Version 1.2019. NCCN. https://www.nccn.org/. Oct 2018.
  59. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: non-small cell lung cancer. Version 2.2019. NCCN. https://www.nccn.org/. Nov 2018.
  60. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: lung cancer screening. Version 2.2019. NCCN. https://www.nccn.org/. Aug 2018.
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Oncology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Jairia Dela Cruz, 2 days ago
In breast cancer, especially hormone-negative tumours, an ultrasound-guided core biopsy (CNB) is useful for predicting pathologic complete response (pCR) to chemotherapy and may thus help to avoid surgery for some patients, a study has found.
Christina Lau, 14 Feb 2019
Progress in the treatment of rare cancers has been named Advance of the Year by the American Society of Clinical Oncology (ASCO).
Dr. Jay Zhu, Dr. Lai Fung Li, Prof. Chae-Yong Kim, 27 Nov 2019
The current standard of care for glioblastoma multiforme (GBM), an aggressive primary brain tumour with a rapid disease course, consists of maximum safe surgical resection followed by radiotherapy with concomitant temozolomide (TMZ) chemotherapy and subsequent TMZ maintenance. At the 16th Annual Meeting of the Asian Society of Neuro-Oncology (ASNO) in Taipei, Taiwan, experts reviewed the evidence and shared their clinical experience on the use of tumour treating fields (TTFields), a novel treatment modality for GBM. 
Stephen Padilla, 2 days ago
There appears to be no significant survival difference between first-line immune checkpoint inhibitor (ICI) and carboplatin-based chemotherapy in cisplatin-ineligible metastatic urothelial carcinoma patients, according to a Taiwan study presented at the recent 2019 Asia Congress of the European Society for Medical Oncology (ESMO Asia 2019).